These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6217149)

  • 1. Normal suppressor-cell activity in systemic lupus erythematosus. A study on 26 cases.
    Gattringer C; Huber H; Michlmayr G; Braunsteiner H
    Immunobiology; 1982 Oct; 163(1):48-52. PubMed ID: 6217149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypes of T lymphocytes in systemic lupus erythematosus: decreased cytotoxic/suppressor subpopulation is associated with deficient allogeneic cytotoxic responses rather than with concanavalin A-induced suppressor cells.
    Tsokos GC; Balow JE
    Clin Immunol Immunopathol; 1983 Feb; 26(2):267-76. PubMed ID: 6223747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
    Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
    J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of immunoglobulin synthesis of systemic lupus erythematosus patients by concanavalin A-activated normal human spleen cell supernatants.
    Ilfeld DN; Krakauer RS
    Clin Immunol Immunopathol; 1980 Oct; 17(2):196-202. PubMed ID: 6447565
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells.
    Sakane T; Steinberg AD; Green I
    Arthritis Rheum; 1978; 21(6):657-64. PubMed ID: 153749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus].
    Stenina MA; Potapova AA; Biriukov AV; Skripnik AIu; Cheredeev AH
    Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial alterations of immunoregulation in systemic lupus erythematosus.
    Spencer-Green G; Adams LE; Hurtubise P; Kravatz G; Hess EV
    J Rheumatol; 1985 Jun; 12(3):498-503. PubMed ID: 2931520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective concanavalin A-induced suppressor cell activity in lupus nephritis.
    Matsumoto K; Osakabe K; Katayama H; Okano K; Yoshizawa N; Ohi H; Hatano M
    Int Arch Allergy Appl Immunol; 1984; 75(1):48-51. PubMed ID: 6235193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
    Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
    J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
    Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
    Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of T suppressor activity in systemic lupus erythematosus].
    Balestrieri G; Tincani A; Fenini G; Cattaneo R
    Boll Ist Sieroter Milan; 1982; 61(4):330-5. PubMed ID: 6242136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.
    Twomey JJ; Laughter AH; Steinberg AD
    J Clin Invest; 1978 Sep; 62(3):713-5. PubMed ID: 308514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levamisole on in vitro suppressosr cell function in normal humans and patients with systemic lupus erythematosus.
    Rabson A; Blank S; Lomnitzer R
    Immunopharmacology; 1980 Apr; 2(2):103-8. PubMed ID: 6449486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus.
    Gladman D; Keystone E; Urowitz M; Cane D; Poplonski L
    Clin Exp Immunol; 1980 Apr; 40(1):77-82. PubMed ID: 6156046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of diminished suppressor T cell activity in patients with atopy and SLE.
    Lydyard PM; Brostoff J; Pack S; Parry HF
    Immunobiology; 1981; 158(3):173-81. PubMed ID: 6452401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.